531762-BOM

Unjha Formulations Ltd.

23.81-0.1 (-0.33%)
24 Jul, 12:00 AM

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBoxTMWhat is StyleBox?
Stock cannot be classified in any StyleBox. May lack sufficient data or market cap < ₹100 Cr.
QVM scoreWhat is QVM score?
Score not available. Market cap may be < ₹100 Cr or data unavailable.
Analyst ratingWhat is Analyst rating?
No active sell-side coverage. Recommendations not available.
Technical indicatorsSee all >

43 %

Unjha Formulations Ltd. on 1D timeframe is bullish for 10 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

2025
Jul 31
2025
Aug 31
2025
Sept 30
2025
Oct 31
2025
Nov 30
2025
Dec 31
2026
Jan 31
2026
Feb 28
2026
Mar 31
2026
Apr 30
2026
May 31
2026
Jun 30
2026
Jul 25
Multiples
P/E (TTM)
18.21112.46115.45108.9611.2010.919.609.328.729.4512.4012.6215.14
P/B (latest)
3.503.343.433.242.652.582.272.242.092.272.272.312.78
P/S (TTM)
0.730.820.840.800.820.800.700.660.620.670.560.570.68
CAPE (3Y)
-25.1725.8424.3921.6821.1118.5715.1614.1815.3718.8519.1923.02
CAPE (5Y)
-------------
P/E (1Y Forward)
-------------
P/S (1Y Forward)
-------------
Yields (%)
Book to Market
0.290.300.290.310.380.390.440.450.480.440.440.430.36
Earnings yield
5.49%0.89%0.87%0.92%8.93%9.17%10.42%10.73%11.47%10.58%8.06%7.92%6.60%
Operating CF yield
10.87%11.37%11.08%11.74%5.89%6.05%6.87%6.97%7.45%6.87%14.14%13.89%11.58%
FCFE yield
----------11.46%11.25%9.38%
FCFF yield
----------14.20%13.89%11.16%

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance
NIFTY50
NIFTYPHARMA
Add benchmark
Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary
531762-BOMNIFTY50NIFTYPHARMA
Start Period01 Jan 202101 Jan 202101 Jan 2021
End Period24 Jul 202624 Jul 202624 Jul 2026
Cumulative Return172.11%69.54%96.49%
CAGR19.75%9.97%12.93%
Volatility (ann.)62.77%14.3%15.77%
Max Drawdown -52.57%-17.23%-21.71%
RoMaD 0.38%0.58%0.6%
Sharpe0.550.480.63
Sortino0.820.680.91
Sortino/√20.580.480.65

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score
Score not available.
Momentum score
Score not available.
Quality score
Score not available.
QVM score
Score not available.

A comprehensive scorecard to compare Unjha Formulations Ltd. on all metrics with other stocks. Access both rank and scores.

Value
Market
(All Stocks in NSE)
Sector
(Healthcare)
Industry Group
(Pharmaceuticals & Biotechnology)
Industry
(Pharmaceuticals)
Size and Listing
Days since Listing
11,097.00
Enterprise value
9 Cr
Market Cap
11 Cr
Liquidity
Avg daily turnover 1M
0 Cr
Avg daily volume 1M
7,907
Avg daily turnover 3M
0 Cr
Avg daily volume 3M
3,230
Bid Ask Spread
0.34%
Delivery Percentage
96.16%
Volume surge ratio
2.55
Ownership
DII Holding %
0.00%
QoQ change DII holding %
0.00%
FII Holding %
0.00%
QoQ change FII holding %
0.00%
QoQ change Gov holding %
0.00%
Promoter holding %
36.92%
QoQ change Promoter holding %
0.00%
Promoter pledged %
0.00%
Retail Holding %
62.14%
QoQ change Retail holding %
0.00%

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans
Benjamin Graham's Value
Piotroski F-Score
Dreman contrarian value
Peter Lynch Growth/Value
O'Shaugnessy Value
Templeton Growth/Value
Warren Buffet’s Consistent Compounders
John Neff’s contrarian value
Richard Driehaus Momentum Strategy
O'Shaughnessy Tiny Titans
1
Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

60.0 / 100

Unjha Formulations Ltd. passes 3 out of 5 of this checklist's rules
Hits
Misses

Frequently Asked Questions

What is the PB ratio of Unjha Formulations Ltd.?
The Price-to-Book (PB) ratio of Unjha Formulations Ltd. is 2.78. It compares the stock's market price to its book value per share.
What is the EV/EBITDA of Unjha Formulations Ltd.?
The EV/EBITDA of Unjha Formulations Ltd. is 9.60. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.
What is the debt-to-equity ratio of Unjha Formulations Ltd.?
The debt-to-equity (D/E) ratio of Unjha Formulations Ltd. is 0.00. The interest coverage ratio stands at 101.03x, reflecting the company's capacity to service its debt from operating earnings. A lower D/E ratio generally indicates a more financially stable company with less leverage.
What is the promoter holding in Unjha Formulations Ltd.?
Promoters hold 36.92% of Unjha Formulations Ltd. shares as per the latest quarterly shareholding disclosure.
What is the operating profit margin of Unjha Formulations Ltd.?
The operating profit margin of Unjha Formulations Ltd. is -, reflecting how much profit the company earns from its core operations relative to revenue.
What is the net profit margin of Unjha Formulations Ltd.?
The net profit margin of Unjha Formulations Ltd. is 4.52%, indicating the percentage of revenue that remains as profit after all expenses.
What is the Sharpely score for Unjha Formulations Ltd.?
Unjha Formulations Ltd. operates in the Healthcare sector. Visit the Scorecard and Checklist sections on the Analysis tab to see how Unjha Formulations Ltd. scores on quality, growth, value and momentum parameters.